Plains GP Holdings, L.P. (PAGP) Financials

PAGP

Trailing 12 months to June 30, 2026

Revenue $52.3B +12.2% YoY

Net Income $554.0M +307.4% YoY

Free Cash Flow $2.4B +6.8% YoY

Operating Cash Flow $3.0B +8.3% YoY

Market Cap $6.4B as of Sep 18, 2026

Price / Sales 0.1x on $52.3B revenue, trailing 12 months to June 30, 2026

Price / Earnings 11.6x on $554.0M net income, trailing 12 months to June 30, 2026

Price / Book n/m no shareholder equity reported

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 10, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PAGP SEC filings page.

Plains GP Holdings, L.P. (PAGP) reported $52.3B in revenue over the twelve months to Jun 30, 2026, up 12.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PAGP FY2025 2026-08-29

Plains’ FY2025 profile is defined by margin expansion and cash generation despite lower revenue and a heavier debt load.

The margin step-up cannot be attributed to scale: revenue fell to $44.3B in FY2025 while gross margin rose to 8.7% and operating margin reached 3.2%. That combination indicates better profitability per sales dollar, although the available lines cannot distinguish whether mix or cost changes drove it.

Cash conversion strengthened with earnings: operating cash flow increased from $2.5B in FY2024 to $2.9B in FY2025, while free cash flow reached $2.3B. Free cash flow exceeded net income in both years, indicating that non-cash charges and working-capital movements materially support profit conversion.

The funding structure became more demanding: long-term debt rose from $7.2B to $10.7B, while the current ratio remained below 1.0x, leaving short-term assets below short-term obligations. Investing cash flow of -$3.4B was much larger than $643M of capital expenditures, indicating cash deployment beyond routine physical reinvestment.

Financial Health Signals

Financial Health Score 36/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Plains GP Holdings, L.P.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Plains GP Holdings, L.P. has an operating margin of 3.2%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 42/100, indicating healthy but not exceptional operating efficiency. This is up from 1.8% the prior year.

Growth

Plains GP Holdings, L.P.'s revenue declined 9.5% year-over-year, from $48.9B to $44.3B. This contraction results in a growth score of 35/100.

Leverage

Liquidity

Plains GP Holdings, L.P.'s current ratio of 0.96 indicates adequate short-term liquidity, earning a score of 30/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Plains GP Holdings, L.P. has a free cash flow margin of 5.2%, earning a moderate score of 47/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Piotroski F-Score Neutral

5/9

Plains GP Holdings, L.P. passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.66x

For every $1 of reported earnings, Plains GP Holdings, L.P. generates $1.66 in operating cash flow ($2.9B OCF vs $1.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.06x

Plains GP Holdings, L.P. earns $3.06 in operating income for every $1 of interest expense ($1.4B vs $467.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$17.7B

YoY+66.3%

QoQ+41.9%

5Y CAGR+12.2%

10Y CAGR+13.6%

Plains GP Holdings, L.P. generated $17.7B in revenue in Q2 2026. This represents an increase of 66.3% from the same quarter a year earlier. Against the prior quarter it is up 41.9%.

EBITDA

$639.0M

YoY+35.4%

QoQ-1.1%

10Y CAGR+6.2%

Plains GP Holdings, L.P.'s EBITDA was $639.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 35.4% from the same quarter a year earlier. Against the prior quarter it is down 1.1%.

Net Income

$389.0M

YoY+1196.7%

QoQ+1845.0%

10Y CAGR+24.9%

Plains GP Holdings, L.P. reported $389.0M in net income in Q2 2026. This represents an increase of 1196.7% from the same quarter a year earlier. Against the prior quarter it is up 1845.0%.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$814.0M

YoY+55.9%

QoQ+182.6%

5Y CAGR+40.4%

Plains GP Holdings, L.P. generated $814.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 55.9% from the same quarter a year earlier. Against the prior quarter it is up 182.6%.

Cash & Debt

$1.1B

YoY+130.4%

QoQ+516.3%

5Y CAGR+109.9%

10Y CAGR+39.9%

Plains GP Holdings, L.P. held $1.1B in cash against $8.4B in long-term debt as of Q2 2026.

Shares Outstanding

198M

YoY+0.1%

QoQ0.0%

5Y CAGR+0.4%

10Y CAGR-3.0%

Plains GP Holdings, L.P. had 198M shares outstanding in Q2 2026. This represents an increase of 0.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

6.4%

YoY-1.9pp

QoQ-1.4pp

Plains GP Holdings, L.P.'s gross margin was 6.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Operating Margin

2.2%

YoY0.0pp

QoQ-1.0pp

5Y change+4.7pp

10Y change-0.7pp

Plains GP Holdings, L.P.'s operating margin was 2.2% in Q2 2026, reflecting core business profitability. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 1.0 percentage points.

Net Margin

2.2%

YoY+1.9pp

QoQ+2.0pp

5Y change+2.9pp

10Y change+1.3pp

Plains GP Holdings, L.P.'s net profit margin was 2.2% in Q2 2026, showing the share of revenue converted to profit. This is up 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$138.0M

YoY-18.8%

QoQ+6.2%

5Y CAGR+10.2%

10Y CAGR-8.3%

Plains GP Holdings, L.P. invested $138.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 18.8% from the same quarter a year earlier. Against the prior quarter it is up 6.2%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

PAGP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PAGP quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$52.3B	$44.3B-9.5%	$48.9B+3.3%	$47.3B-17.4%	$57.3B+36.3%	$42.1B+80.7%	$23.3B-30.8%	$33.7B-1.1%	$34.1B+29.9%	$26.2B+29.9%	$20.2B-12.8%	$23.2B-46.7%	$43.5B+2.9%	$42.2B+11.8%	$37.8B+10.3%	$34.3B
Cost of Revenue	N/A	$40.4B-10.5%	$45.2B+2.8%	$43.9B-17.4%	$53.2B+38.1%	$38.5B+88.5%	$20.4B-30.6%	$29.5B-1.1%	$29.8B+29.6%	$23.0B+33.4%	$17.2B-12.6%	$19.7B-50.1%	$39.5B+2.7%	$38.5B	N/A	N/A
Gross Profit	N/A	$3.8B+2.7%	$3.7B+9.6%	$3.4B-18.4%	$4.2B+16.6%	$3.6B+25.0%	$2.9B-32.2%	$4.2B-1.1%	$4.3B+31.6%	$3.2B+9.8%	$2.9B-13.9%	$3.4B+49.5%	$2.3B+5.7%	$2.2B+11.4%	$1.9B+24.7%	$1.6B
SG&A Expenses	N/A	$348.0M+4.2%	$334.0M+9.5%	$305.0M-7.6%	$330.0M+10.7%	$298.0M+8.0%	$276.0M-8.6%	$302.0M-5.6%	$320.0M+14.3%	$280.0M-0.7%	$282.0M+0.4%	$281.0M-15.1%	$331.0M-8.1%	$360.0M+5.3%	$342.0M+16.3%	$294.0M
Operating Income	$1.6B	$1.4B+65.7%	$862.0M-31.0%	$1.2B-2.7%	$1.3B+52.5%	$842.0M+135.3%	-$2.4B-220.4%	$2.0B-12.9%	$2.3B+98.1%	$1.1B+15.9%	$990.0M-21.3%	$1.3B-29.8%	$1.8B+3.3%	$1.7B+21.8%	$1.4B+9.8%	$1.3B
EBITDA	N/A	$2.4B+35.1%	$1.8B-18.4%	$2.2B-4.0%	$2.3B+39.1%	$1.6B+193.7%	-$1.7B-166.8%	$2.6B-7.5%	$2.8B+67.6%	$1.7B+10.7%	$1.5B-11.0%	$1.7B-22.3%	$2.2B+3.6%	$2.1B+10.2%	$1.9B+24.6%	$1.5B
Interest Expense	N/A	$467.0M+22.3%	$382.0M-1.0%	$386.0M-4.7%	$405.0M-4.7%	$425.0M-2.5%	$436.0M+2.6%	$425.0M-1.4%	$431.0M-15.5%	$510.0M+6.3%	$480.0M+8.4%	$443.0M+24.1%	$357.0M+11.9%	$319.0M+8.1%	$295.0M+13.9%	$259.0M
Income Tax	N/A	$92.0M-25.8%	$124.0M-3.9%	$129.0M-47.6%	$246.0M+119.6%	$112.0M+167.1%	-$167.0M-194.9%	$176.0M-41.7%	$302.0M-67.8%	$937.0M+1101.3%	$78.0M-57.1%	$182.0M-14.2%	$212.0M+100.0%	$106.0M+92.7%	$55.0M+22.2%	$45.0M
Net Income	$554.0M	$1.8B+59.5%	$1.1B-26.0%	$1.5B+22.0%	$1.2B+89.8%	$648.0M+214.1%	-$568.0M-271.6%	$331.0M-0.9%	$334.0M+145.7%	-$731.0M-877.7%	$94.0M-20.3%	$118.0M+68.6%	$70.0M+366.7%	$15.0M+400.0%	$3.0M+50.0%	$2.0M
EPS (Basic)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0.48+380.0%	$0.10	N/A	N/A
EPS (Diluted)	—	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0.47+370.0%	$0.10	N/A	N/A
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	650M+392.4%	132M	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$17.7B+66.3%	$12.5B+8.7%	$10.6B-12.2%	$11.6B-7.0%	$10.6B-16.6%	$11.5B-1.4%	$12.0B+6.3%	$12.5B+3.2%
Cost of Revenue	$16.6B+69.7%	$11.5B+9.3%	N/A	$10.6B-8.3%	$9.8B-17.6%	$10.5B-3.7%	N/A	$11.5B+3.9%
Gross Profit	$1.1B+28.6%	$977.0M+1.8%	N/A	$993.0M+8.4%	$884.0M-3.8%	$960.0M+33.0%	N/A	$916.0M-5.1%
SG&A Expenses	$111.0M+32.1%	$83.0M-3.5%	N/A	$84.0M-3.4%	$84.0M+3.7%	$86.0M-11.3%	N/A	$87.0M-6.5%
Operating Income	$397.0M+67.5%	$403.0M+13.5%	$354.0M+2182.4%	$483.0M+147.7%	$237.0M-28.2%	$355.0M0.0%	-$17.0M-109.9%	$195.0M-15.9%
EBITDA	$639.0M+35.4%	$646.0M+10.1%	$611.0M+192.3%	$713.0M+69.4%	$472.0M-15.1%	$587.0M-3.6%	$209.0M-31.5%	$421.0M-14.6%
Interest Expense	$135.0M+22.7%	$144.0M+34.6%	N/A	$112.0M+15.5%	$110.0M+14.6%	$107.0M+12.6%	N/A	$97.0M0.0%
Income Tax	$209.0M+1206.3%	$8.0M-75.0%	N/A	$30.0M+66.7%	$16.0M-75.0%	$32.0M+14.3%	N/A	$18.0M+460.0%
Net Income	$389.0M+1196.7%	$20.0M-76.2%	$62.0M+663.6%	$83.0M+151.5%	$30.0M-23.1%	$84.0M+100.0%	-$11.0M-100.8%	$33.0M+13.8%

Not reported in any period shown, so not listed: R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

PAGP Balance Sheet

PAGP quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$31.3B+12.7%	$27.8B-2.9%	$28.6B-2.1%	$29.2B-2.6%	$30.0B+15.5%	$26.0B-13.4%	$30.0B+11.7%	$26.8B+0.3%	$26.8B+2.5%	$26.1B+8.1%	$24.1B+0.9%	$23.9B+11.7%	$21.4B+11.2%	$19.3B+24.9%	$15.4B
Current Assets	$4.7B-1.5%	$4.8B-2.8%	$4.9B-8.2%	$5.4B-12.7%	$6.1B+67.4%	$3.7B-20.5%	$4.6B+30.5%	$3.5B-11.7%	$4.0B-6.4%	$4.3B+43.8%	$3.0B-28.9%	$4.2B-15.8%	$5.0B-3.6%	$5.1B	N/A
Cash & Equivalents	$329.0M-5.7%	$349.0M-23.0%	$453.0M+12.1%	$404.0M-10.6%	$452.0M+1708.0%	$25.0M-46.8%	$47.0M-31.9%	$69.0M+72.5%	$40.0M-20.0%	$50.0M+66.7%	$30.0M-92.6%	$404.0M+839.5%	$43.0M+72.0%	$25.0M-7.4%	$27.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$211.0M-19.2%	$261.0M-52.4%	$548.0M-24.8%	$729.0M-6.9%	$783.0M+21.0%	$647.0M+7.1%	$604.0M-5.6%	$640.0M-10.2%	$713.0M-46.9%	$1.3B+46.6%	$916.0M+2.8%	$891.0M-16.3%	$1.1B-11.9%	$1.2B	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$2.5B+0.8%	$2.5B-1.8%	$2.6B+9.5%	$2.3B-2.5%	$2.4B-2.4%	$2.5B-1.5%	$2.5B-1.3%	$2.5B+36.7%	$1.9B
Total Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$27.1B+7.5%	$25.2B	N/A	N/A	N/A	N/A
Current Liabilities	$4.9B-0.4%	$4.9B-1.6%	$5.0B-15.1%	$5.9B-5.5%	$6.2B+46.5%	$4.3B-15.2%	$5.0B+45.1%	$3.5B-23.7%	$4.5B-2.9%	$4.7B+36.9%	$3.4B-28.3%	$4.8B-12.1%	$5.4B+4.4%	$5.2B	N/A
Non-Current Liabilities	$12.2B+42.8%	$8.5B-1.2%	$8.6B-0.6%	$8.7B-9.3%	$9.6B-8.9%	$10.5B+0.4%	$10.5B+4.1%	$10.1B+1.9%	$9.9B-8.1%	$10.7B-6.7%	$11.5B+17.5%	$9.8B+26.1%	$7.8B+9.2%	$7.1B	N/A
Long-Term Debt	$10.7B+48.3%	$7.2B-1.3%	$7.3B+0.2%	$7.3B-13.2%	$8.4B-10.5%	$9.4B+2.1%	$9.2B+0.5%	$9.1B-0.4%	$9.2B-9.3%	$10.1B-7.4%	$10.9B+18.3%	$9.2B+27.8%	$7.2B+10.9%	$6.5B	N/A
Total Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$1.0B+6.7%	-$1.1B	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$30.2B+6.8%	$32.8B+16.0%	$31.3B+12.7%	$29.3B+3.2%	$28.3B-1.3%	$28.3B-1.2%	$27.8B-2.9%	$28.4B-2.2%
Current Assets	$6.5B+40.2%	$6.2B+30.2%	$4.7B-1.5%	$5.6B+8.1%	$4.7B-13.4%	$4.7B-5.5%	$4.8B-2.8%	$5.2B-3.2%
Cash & Equivalents	$1.1B+130.4%	$172.0M-59.9%	$329.0M-5.7%	$1.2B+84.2%	$460.0M-17.3%	$429.0M+28.4%	$349.0M-23.0%	$641.0M+144.7%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$84.0M-44.4%	$380.0M+13.4%	$211.0M-19.2%	$184.0M-57.8%	$151.0M-69.9%	$335.0M-26.0%	$261.0M-52.4%	$436.0M-29.3%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Current Liabilities	$5.9B+25.9%	$6.5B+39.5%	$4.9B-0.4%	$5.4B+4.5%	$4.6B-13.9%	$4.7B-9.0%	$4.9B-1.6%	$5.1B-8.6%
Non-Current Liabilities	$9.1B-4.8%	$12.3B+29.1%	$12.2B+42.8%	$9.7B+14.8%	$9.5B+12.5%	$9.5B+11.0%	$8.5B-1.2%	$8.5B-1.1%
Long-Term Debt	$8.4B+2.8%	$11.0B+33.5%	$10.7B+48.3%	$8.4B+17.0%	$8.2B+13.8%	$8.2B+12.3%	$7.2B-1.3%	$7.2B-1.2%

Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Total Liabilities, Total Equity, Retained Earnings.

PAGP Cash Flow Statement

PAGP quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$3.0B	$2.9B+18.0%	$2.5B-8.7%	$2.7B+13.2%	$2.4B+20.7%	$2.0B+31.9%	$1.5B-39.6%	$2.5B-4.0%	$2.6B+4.3%	$2.5B+247.6%	$718.0M-46.7%	$1.3B-32.2%	$2.0B+2.1%	$1.9B+58.1%	$1.2B-47.7%	$2.4B
Depreciation & Amortization	N/A	$953.0M+5.8%	$901.0M-1.2%	$912.0M-5.8%	$968.0M+24.6%	$777.0M+18.4%	$656.0M+8.6%	$604.0M+15.9%	$521.0M+0.4%	$519.0M+0.8%	$515.0M+18.9%	$433.0M+12.2%	$386.0M+4.9%	$368.0M-23.8%	$483.0M+107.3%	$233.0M
Stock-Based Compensation	N/A	$50.0M-3.8%	$52.0M+2.0%	$51.0M+24.4%	$41.0M+70.8%	$24.0M+50.0%	$16.0M-54.3%	$35.0M-55.7%	$79.0M+92.7%	$41.0M-31.7%	$60.0M+122.2%	$27.0M-72.7%	$99.0M-14.7%	$116.0M+14.9%	$101.0M-8.2%	$110.0M
Capital Expenditures	$601.0M	$643.0M+43.5%	$448.0M+9.8%	$408.0M-10.3%	$455.0M+35.4%	$336.0M-54.5%	$738.0M-37.5%	$1.2B-27.7%	$1.6B+59.6%	$1.0B-23.2%	$1.3B-35.8%	$2.1B+7.6%	$1.9B+19.8%	$1.6B+34.0%	$1.2B+89.6%	$635.0M
Free Cash Flow	$2.4B	$2.3B+12.4%	$2.0B-12.0%	$2.3B+18.7%	$1.9B+17.8%	$1.7B+114.4%	$772.0M-41.5%	$1.3B+36.0%	$970.0M-34.1%	$1.5B+339.0%	-$616.0M+15.8%	-$732.0M-1407.1%	$56.0M-83.3%	$335.0M+1096.4%	$28.0M-98.4%	$1.7B
Investing Cash Flow	$756.0M	-$3.4B-293.0%	-$875.0M-24.6%	-$702.0M-33.5%	-$526.0M-236.3%	$386.0M+135.3%	-$1.1B+38.1%	-$1.8B-117.1%	-$813.0M+48.2%	-$1.6B-23.3%	-$1.3B+49.7%	-$2.5B	N/A	N/A	N/A	N/A
Financing Cash Flow	-$3.1B	$474.0M+127.8%	-$1.7B+13.6%	-$2.0B-2.3%	-$1.9B+2.6%	-$2.0B-360.2%	-$430.0M+40.0%	-$717.0M+59.1%	-$1.8B-86.5%	-$940.0M-264.6%	$571.0M-29.8%	$813.0M	N/A	N/A	N/A	N/A
Share Buybacks	N/A	$8.0M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$952.0M+37.6%	$418.0M-34.5%	$784.0M+8.0%	$817.0M+18.8%	$692.0M+6.1%	$638.0M+52.6%	$726.0M-28.1%	$688.0M+728.9%
Depreciation & Amortization	$242.0M+3.0%	$243.0M+4.7%	$257.0M+13.7%	$230.0M+1.8%	$235.0M+4.0%	$232.0M-8.7%	$226.0M+68.7%	$226.0M-13.4%
Capital Expenditures	$138.0M-18.8%	$130.0M-7.1%	$148.0M+39.6%	$185.0M+69.7%	$170.0M+123.7%	$140.0M-10.8%	$106.0M+2550.0%	$109.0M-20.4%
Free Cash Flow	$814.0M+55.9%	$288.0M-42.2%	$636.0M+2.6%	$632.0M+9.2%	$522.0M-9.4%	$498.0M+90.8%	$620.0M-38.4%	$579.0M+1172.2%
Investing Cash Flow	$3.3B+1317.2%	-$233.0M+71.6%	-$1.9B-634.1%	-$408.0M-111.4%	-$274.0M-74.5%	-$819.0M-213.8%	-$264.0M-2.3%	-$193.0M+55.9%
Financing Cash Flow	-$3.4B-731.9%	-$339.0M-229.4%	$301.0M+140.3%	$318.0M+177.0%	-$407.0M-50.2%	$262.0M+196.3%	-$746.0M-32.0%	-$413.0M-34.5%

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

PAGP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PAGP quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	8.6%+1.0pp	7.6%+0.4pp	7.2%-0.1pp	7.3%-1.2pp	8.5%-3.8pp	12.3%-0.2pp	12.5%0.0pp	12.5%+0.2pp	12.3%-2.3pp	14.6%-0.2pp	14.8%+9.5pp	5.3%+0.1pp	5.1%0.0pp	5.1%+0.6pp	4.5%
Operating Margin	3.2%+1.5pp	1.8%-0.9pp	2.6%+0.4pp	2.2%+0.2pp	2.0%+12.2pp	-10.2%-16.1pp	5.9%-0.8pp	6.7%+2.3pp	4.4%-0.5pp	4.9%-0.5pp	5.4%+1.3pp	4.1%0.0pp	4.1%+0.3pp	3.8%0.0pp	3.8%
Net Margin	4.0%+1.7pp	2.3%-0.9pp	3.2%+1.0pp	2.1%+0.6pp	1.5%+4.0pp	-2.4%-3.4pp	1.0%0.0pp	1.0%+3.8pp	-2.8%-3.3pp	0.5%0.0pp	0.5%+0.4pp	0.2%+0.1pp	0.0%0.0pp	0.0%0.0pp	0.0%
Return on Assets	5.7%+1.7pp	4.0%-1.2pp	5.3%+1.0pp	4.2%+2.0pp	2.2%+4.3pp	-2.2%-3.3pp	1.1%-0.1pp	1.2%+4.0pp	-2.7%-3.1pp	0.4%-0.1pp	0.5%+0.2pp	0.3%+0.2pp	0.1%+0.1pp	0.0%0.0pp	0.0%
Current Ratio	0.960.0x	0.970.0x	0.98+0.1x	0.91-0.1x	0.98+0.1x	0.86-0.1x	0.92-0.1x	1.02+0.1x	0.880.0x	0.920.0x	0.870.0x	0.880.0x	0.92-0.1x	0.99	N/A
Asset Turnover	1.42-0.3x	1.76+0.1x	1.66-0.3x	1.96+0.6x	1.40+0.5x	0.90-0.2x	1.12-0.1x	1.27+0.3x	0.98+0.2x	0.77-0.2x	0.96-0.9x	1.82-0.2x	1.970.0x	1.96-0.3x	2.22
FCF Margin	5.2%+1.0pp	4.2%-0.7pp	4.9%+1.5pp	3.4%-0.5pp	3.9%+0.6pp	3.3%-0.6pp	3.9%+1.1pp	2.9%-2.8pp	5.6%+8.7pp	-3.0%+0.1pp	-3.2%-3.3pp	0.1%-0.7pp	0.8%+0.7pp	0.1%-5.0pp	5.0%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Gross Margin	6.4%-1.9pp	7.8%-0.5pp	N/A	8.6%+1.2pp	8.3%+1.1pp	8.4%+2.2pp	N/A	7.3%-0.6pp
Operating Margin	2.2%0.0pp	3.2%+0.1pp	3.4%+3.5pp	4.2%+2.6pp	2.2%-0.4pp	3.1%0.0pp	-0.1%-1.7pp	1.6%-0.3pp
Net Margin	2.2%+1.9pp	0.2%-0.6pp	0.6%+0.7pp	0.7%+0.5pp	0.3%0.0pp	0.7%+0.4pp	-0.1%-12.0pp	0.3%0.0pp
Return on Assets	1.3%+1.2pp	0.1%-0.2pp	0.2%+0.2pp	0.3%+0.2pp	0.1%0.0pp	0.3%+0.1pp	0.0%-4.8pp	0.1%0.0pp
Current Ratio	1.12+0.1x	0.94-0.1x	0.960.0x	1.040.0x	1.000.0x	1.010.0x	0.970.0x	1.01+0.1x
Asset Turnover	0.59+0.2x	0.380.0x	0.34-0.1x	0.400.0x	0.38-0.1x	0.410.0x	0.430.0x	0.440.0x
FCF Margin	4.6%-0.3pp	2.3%-2.0pp	6.0%+0.9pp	5.5%+0.8pp	4.9%+0.4pp	4.3%+2.1pp	5.1%-3.7pp	4.7%+5.1pp

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Note: The current ratio is below 1.0 (0.96), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Plains GP Holdings, L.P. PAGP	FY2025	$44.3B	$1.8B	4.0%	$6.4B	36/100
Golar LNG Ltd GLNG	FY2025	$393.5M	$65.7M	16.7%	$5.1B	41/100
South Bow Corporation SOBO	FY2025	$2.0B	$433.0M	21.8%	$7.4B	66/100
Scorpio Tankers Inc. STNG	FY2025	$938.2M	$344.3M	36.7%	$4.3B	33/100
CMB.TECH NV CMBT	FY2025	$1.7B	$139.1M	8.3%	$5.7B	33/100

Where Plains GP Holdings, L.P. Ranks

Frequently Asked Questions

What is Plains GP Holdings, L.P.'s annual revenue?

Plains GP Holdings, L.P. (PAGP) reported $44.3B in total revenue for fiscal year 2025. This represents a -9.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Plains GP Holdings, L.P.'s revenue growing?

Plains GP Holdings, L.P. (PAGP) revenue declined by 9.5% year-over-year, from $48.9B to $44.3B in fiscal year 2025.

Is Plains GP Holdings, L.P. profitable?

Yes, Plains GP Holdings, L.P. (PAGP) reported a net income of $1.8B in fiscal year 2025, with a net profit margin of 4.0%.

What is Plains GP Holdings, L.P.'s EBITDA?

Plains GP Holdings, L.P. (PAGP) had EBITDA of $2.4B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Plains GP Holdings, L.P. have?

As of fiscal year 2025, Plains GP Holdings, L.P. (PAGP) had $329.0M in cash and equivalents against $10.7B in long-term debt.

What is Plains GP Holdings, L.P.'s gross margin?

Plains GP Holdings, L.P. (PAGP) had a gross margin of 8.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Plains GP Holdings, L.P.'s operating margin?

Plains GP Holdings, L.P. (PAGP) had an operating margin of 3.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Plains GP Holdings, L.P.'s net profit margin?

Plains GP Holdings, L.P. (PAGP) had a net profit margin of 4.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Plains GP Holdings, L.P.'s free cash flow?

Plains GP Holdings, L.P. (PAGP) generated $2.3B in free cash flow during fiscal year 2025. This represents a 12.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Plains GP Holdings, L.P.'s operating cash flow?

Plains GP Holdings, L.P. (PAGP) generated $2.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Plains GP Holdings, L.P.'s total assets?

Plains GP Holdings, L.P. (PAGP) had $31.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Plains GP Holdings, L.P.'s capital expenditures?

Plains GP Holdings, L.P. (PAGP) invested $643.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Plains GP Holdings, L.P. buy back shares?

Yes, Plains GP Holdings, L.P. (PAGP) spent $8.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Plains GP Holdings, L.P. have outstanding?

Plains GP Holdings, L.P. (PAGP) had 198M shares outstanding as of fiscal year 2025.

What is Plains GP Holdings, L.P.'s current ratio?

Plains GP Holdings, L.P. (PAGP) had a current ratio of 0.96 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Plains GP Holdings, L.P.'s return on assets (ROA)?

Plains GP Holdings, L.P. (PAGP) had a return on assets of 5.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Plains GP Holdings, L.P.'s P/E ratio?

Plains GP Holdings, L.P. (PAGP) trades at 11.6x earnings, its market capitalization divided by net income of $554.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $6.4B as of Sep 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Plains GP Holdings, L.P.'s price-to-sales ratio?

Plains GP Holdings, L.P. (PAGP) trades at 0.1x sales, its market capitalization divided by revenue of $52.3B revenue, trailing 12 months to June 30, 2026. The market capitalization is $6.4B as of Sep 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Plains GP Holdings, L.P.'s Piotroski F-Score?

Plains GP Holdings, L.P. (PAGP) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Plains GP Holdings, L.P.'s earnings high quality?

Plains GP Holdings, L.P. (PAGP) has an earnings quality ratio of 1.66x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Plains GP Holdings, L.P. cover its interest payments?

Plains GP Holdings, L.P. (PAGP) has an interest coverage ratio of 3.06x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Plains GP Holdings, L.P.?

Plains GP Holdings, L.P. (PAGP) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.